Skip to content
Menu

First Trust Nasdaq Pharmaceuticals ETF FTXH

Full chart Compare
Set alert

Price alert · FTXH

All alert types
41.71 USD -0.37 (-0.87%)

Regular-session close

42.34 +0.63 +1.52%

After hours · Nov 20, 6:59 PM ET

41.68 Day range 42.59
31.54 52-week range 45.10
YTD
+26.62%
1 year
+32.66%

First Trust Nasdaq Pharmaceuticals ETF

Issuer
First Trust
Asset class
Sector Equity
Expense ratio
0.60%
Assets under management
$1.21B
NAV
44.35
Holdings
50
Inception
2016-09-20
Top 10 weight
56.06%

Top holdings

  1. LLY Eli Lilly and Company 8.28%
  2. ABBV AbbVie Inc. 7.66%
  3. JNJ Johnson & Johnson 7.06%
  4. PFE Pfizer Inc. 6.89%
  5. MRK Merck & Co., Inc. 6.70%
  6. VTRS Viatris Inc. 4.22%
  7. BIIB Biogen Inc. 3.91%
  8. GILD Gilead Sciences, Inc. 3.90%
  9. REGN Regeneron Pharmaceuticals, Inc. 3.83%
  10. AMGN Amgen Inc. 3.62%
  11. ZTS Zoetis Inc. 3.57%
  12. UTHR United Therapeutics Corporation 3.42%
  13. VRTX Vertex Pharmaceuticals Incorporated 3.36%
  14. INCY Incyte Corporation 3.23%
  15. BMY Bristol-Myers Squibb Company 3.14%
  16. EXEL Exelixis, Inc. 2.63%
  17. JAZZ Jazz Pharmaceuticals Plc 2.61%
  18. ILMN Illumina, Inc. 1.66%
  19. MEDP Medpace Holdings, Inc. 1.53%
  20. HALO Halozyme Therapeutics, Inc. 1.38%
  21. NBIX Neurocrine Biosciences, Inc. 1.34%
  22. ELAN Elanco Animal Health Incorporated 1.28%
  23. CRL Charles River Laboratories International, Inc. 1.12%
  24. BMRN BioMarin Pharmaceutical Inc. 1.12%
  25. MRNA Moderna, Inc. 0.83%

Sector weights

  1. Healthcare 100.00%

Country weights

  1. United States 99.49%
  2. United Kingdom 0.51%

Updated 2026-11-11

Held by funds

2 US ETFs and mutual funds hold FTXH · largest positions

  1. FV 22.90% of fund $856.16M
  2. FVC 22.90% of fund $24.56M